What is Replimune Group's G&A?

Replimune Group (REPL) reported G&A of $18.73M in Q4 2025.

How has Replimune Group's G&A changed year-over-year?

Replimune Group's G&A increased by 4.0% year-over-year, from $18.02M to $18.73M.

What is the long-term trend for Replimune Group's G&A?

Over 3 years (2022 to 2025), Replimune Group's G&A has grown at a 23.6% compound annual growth rate (CAGR), from $38.77M to $73.23M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Replimune Group REPL G&A

G&A at other companies

Inhibrx Biosciences, Inc.INBX

$5.71M-5.2%

ImmunomeIMNM

$12.95M+21.1%

CG OncologyCGON

$20.78M+40.5%

Erasca, Inc.ERAS

$10.65M+10.2%

Relay Therapeutics, Inc.RLAY

$11.03M-41.2%

IDEAYA Biosciences, Inc.IDYA

$19.38M+43.5%

Other financials

Income statement

See full

Operating income-$71.9M-8.9%

Net income-$70.9M-6.9%

EPS (diluted)-$0.77+2.5%

Balance sheet

See full

Cash & equivalents$124.7M-28.3%

Total debt$79.2M+0.5%

Total equity$210.5M-56.4%

Total assets$333.6M-44.7%

Cash flow

See full

Operating cash flow-$66.0M-30.1%

CapEx$135.0K-92.5%

Free cash flow-$66.1M-25.9%

Valuation

See full

Market cap$930.59M+28.6%

Enterprise value$885.15M+28.3%

Returns & leverage

See full

Return on equity-90.9%+362pp

Debt / equity0.4×+0.2×

Current ratio5.6×-5.8×

Where this comes from

Reported directly by Replimune Group in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Replimune Group’s 10-Q, filed February 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Replimune Group's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Replimune Group's G&A?: Replimune Group (REPL) reported G&A of $18.73M in Q4 2025.
How has Replimune Group's G&A changed year-over-year?: Replimune Group's G&A increased by 4.0% year-over-year, from $18.02M to $18.73M.
What is the long-term trend for Replimune Group's G&A?: Over 3 years (2022 to 2025), Replimune Group's G&A has grown at a 23.6% compound annual growth rate (CAGR), from $38.77M to $73.23M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.